UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
---|---|---|---|---|
Q2FZV2 (MNHB1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Na(+)/H(+) antiporter subunit B1; Mnh complex subunit B1; | |
P0A088 (MSRB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Peptide methionine sulfoxide reductase MsrB; Peptide-methionine (R)-S-oxide reductase; | |
Q2G2R4 (LACA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Galactose-6-phosphate isomerase subunit LacA; | |
Q2FXW1 (YQGF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Putative pre-16S rRNA nuclease; | |
Q2G296 (FTHS_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Formate--tetrahydrofolate ligase; Formyltetrahydrofolate synthetase; | |
Q2FZ97 (MRAZ_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Transcriptional regulator MraZ; | |
Q2FVC1 (PGCA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Phosphoglucomutase; Alpha-phosphoglucomutase; Glucose phosphomutase; | |
Q2G0F8 (SYR_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Arginine--tRNA ligase; Arginyl-tRNA synthetase; | |
Q2G2K5 (URE1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Urease subunit alpha; Urea amidohydrolase subunit alpha; | |
Q2FUW9 (SASF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Surface protein F; | |
Q2FWI8 (MAZF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Endoribonuclease MazF; Toxin MazF; mRNA interferase MazF; | |
P68805 (MSCL_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Large-conductance mechanosensitive channel; | |
Q2FXE6 (FLUC1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Fluoride-specific ion channel FluC 1; | |
Q9ZAH6 (ACPS_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Holo-[acyl-carrier-protein] synthase; 4'-phosphopantetheinyl transferase AcpS; | |
Q2G0D1 (SARX_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | HTH-type transcriptional regulator SarX; Staphylococcal accessory regulator X; | |
Q2G2M4 (MRNC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Mini-ribonuclease 3; Mini-RNase III; | |
Q2FWF1 (ATPE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | ATP synthase epsilon chain; ATP synthase F1 sector epsilon subunit; F-ATPase epsilon subunit; | |
Q2G1A5 (RBSD_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | D-ribose pyranase; | |
Q2FZD0 (UVRC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UvrABC system protein C; Excinuclease ABC subunit C; | |
Q2FXZ2 (DNAK_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Chaperone protein DnaK; HSP70; Heat shock 70 kDa protein; Heat shock protein 70; | |
Q2FZZ8 (GCSH_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Glycine cleavage system H protein; Octanoyl/lipoyl carrier protein; | |
Q2G1M8 (SBNF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 2-[(L-alanin-3-ylcarbamoyl)methyl]-3-(2-aminoethylcarbamoyl)-2-hydroxypropanoate synthase; Staphyloferrin B biosynthesis protein SbnF; | |
Q2FUQ3 (MNMG_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG; Glucose-inhibited division protein A; | |
Q2FVS6 (Y2615_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UPF0060 membrane protein SAOUHSC_02615; | |
Q2G1J2 (HDOX2_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Heme oxygenase (staphylobilin-producing) 2; Heme-degrading monooxygenase 2; Iron-regulated surface determinant 2; Iron-responsive surface determinant 2; | |
P60070 (RSBV_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Anti-sigma-B factor antagonist; Anti-anti-sigma-B factor; | |
Q2G0N1 (EFG_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Elongation factor G; | |
Q2FW79 (Y2425_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UPF0457 protein SAOUHSC_02425; | |
Q2FXW0 (Y1721_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UPF0297 protein SAOUHSC_01721; | |
Q2FZF0 (ISDB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Iron-regulated surface determinant protein B; Fur-regulated protein B; Staphylococcal iron-regulated protein H; Staphylococcus aureus surface protein J; | |
Q2FXP7 (SYT_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Threonine--tRNA ligase; Threonyl-tRNA synthetase; | |
Q2G2H9 (MNHG1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Na(+)/H(+) antiporter subunit G1; Mnh complex subunit G1; | |
Q2G2B1 (SART_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | HTH-type transcriptional regulator SarT; Staphylococcal accessory regulator T; | |
Q2FVB2 (F16PC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Fructose-1,6-bisphosphatase class 3; D-fructose-1,6-bisphosphate 1-phosphohydrolase class 3; | |
Q2G093 (LTAS_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Lipoteichoic acid synthase; Glycerol phosphate lipoteichoic acid synthase; LTA synthase; 2.7.8.-; Polyglycerol phosphate synthase; Processed glycerol phosphate lipoteichoic acid synthase; | |
Q2FUQ1 (RNPA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Ribonuclease P protein component; Protein C5; | |
Q2FXE5 (FLUC2_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Fluoride-specific ion channel FluC 2; | |
Q2G200 (Y941_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UPF0738 protein SAOUHSC_00941; | |
Q9F0R1 (SARR_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | HTH-type transcriptional regulator SarR; Staphylococcal accessory regulator R; | |
Q2FZK0 (QOX1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Probable quinol oxidase subunit 1; Quinol oxidase polypeptide I; | |
Q2FYS5 (PARE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | DNA topoisomerase 4 subunit B; Topoisomerase IV subunit B; | |
Q93T05 (MUTL_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | DNA mismatch repair protein MutL; | |
Q2FZV3 (MNHC1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Na(+)/H(+) antiporter subunit C1; Mnh complex subunit C1; | |
Q2G0I5 (Y580_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UPF0741 protein SAOUHSC_00580; | |
Q2FW70 (SFNAD_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | D-ornithine--citrate ligase; | |
Q2FXA0 (Y1977_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UPF0342 protein SAOUHSC_01977; | |
Q2G213 (MNHC2_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Putative antiporter subunit mnhC2; Mrp complex subunit C2; Putative NADH-ubiquinone oxidoreductase subunit mnhC2; | |
Q2FYI5 (GPSB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Cell cycle protein GpsB; Guiding PBP1-shuttling protein; | |
Q2G1Y0 (DNLJ_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | DNA ligase; Polydeoxyribonucleotide synthase [NAD(+)]; | |
Q2FWV6 (SCIN_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Staphylococcal complement inhibitor; |
Staphylococcus aureus is a Gram-positive coccal bacterium that is a member of the Firmicutes, and is frequently found in the nose, respiratory tract, and on the skin. Although S. aureus is not always pathogenic, it is a common cause of skin infections such as abscesses, respiratory infections such as sinusitis, and food poisoning.
An estimated 20% of the human population are long-term carriers of S. aureus. It is one of the five most common causes of hospital-acquired infections and is often the cause of postsurgical wound infections. The emergence of antibiotic-resistant strains of S. aureus such as methicillin-resistant S. aureus (MRSA) is a worldwide problem in clinical medicine. There are currently (2016) no dedicated antibiotics against drug-resistant S. aureus available.
The genome of S. aureus was first sequenced in 2006.
From left to right: i) The number of proteins in the reference proteome of Staphylococcus aureus, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Staphylococcus aureus for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Staphylococcus aureus, please visit UniProtKB.
You can easily download the latest protein sequences for Staphylococcus aureus proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2024_05 that was used for the most up to date SWISS-MODEL Repository.
Proteins in proteome | Sequences modelled | Models |
2,889 | 2,366 | 3,839 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Staphylococcus aureus reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Staphylococcus aureus proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 12-mer | 13-mer | 14-mer | 24-mer | 25-mer | 60-mer |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,713 | 774 | 77 | 156 | 3 | 64 | 5 | 11 | 5 | 7 | 12 | 1 | 3 | 6 | 1 | 1 |